Interaction between effects of genes coding for dopamine and glutamate transmission on striatal and parahippocampal function

Human Brain Mapping

Volumn 34, Issue 9, 2013, Pages 2244-2258

  Pauli, Andreina ^a,b   Prata, Diana P ^a   Mechelli, Andrea ^a   Picchioni, Marco ^a   Fu, Cynthia H Y ^a   Chaddock, Christopher A ^a   Kane, Fergus ^a   Kalidindi, Sridevi ^a   Mcdonald, Colm ^c   Kravariti, Eugenia ^b   Toulopoulou, Timothea ^a   Bramon, Elvira ^a   Walshe, Muriel ^a   Ehlert, Natascha ^a   Georgiades, Anna ^a   Murray, Robin ^a   Collier, David A ^a   Mcguire, Philip ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b UNIVERSITY OF BERN   (Switzerland)

^c NATIONAL UNIVERSITY OF IRELAND   (Ireland)

Author keywords

DAT; Epistasis; Imaging genetics; Psychosis, DAOA G72; Schizophrenia; Verbal fluency

Indexed keywords

DEXTRO AMINO ACID OXIDASE; DOPAMINE; DOPAMINE TRANSPORTER; GLUTAMIC ACID;

ADULT; AMINO ACID TRANSPORT; ANGULAR GYRUS; ARTICLE; BRAIN FUNCTION; BRAIN RADIOGRAPHY; CONTROLLED STUDY; CORPUS STRIATUM; DNA POLYMORPHISM; DOPAMINERGIC TRANSMISSION; FEMALE; FUNCTIONAL MAGNETIC RESONANCE IMAGING; GENE INTERACTION; GENETIC CODE; GENOTYPE; HUMAN; HUMAN EXPERIMENT; INSULA; MALE; NORMAL HUMAN; PARAHIPPOCAMPAL GYRUS; POSTERIOR CINGULATE; PRIORITY JOURNAL; PSYCHOSIS; RETROSPLENIAL CORTEX; SUPRAMARGINAL GYRUS; VERBALIZATION;

DAT; EPISTASIS; IMAGING GENETICS; PSYCHOSIS, DAOA/G72; SCHIZOPHRENIA; VERBAL FLUENCY;

ADULT; BRAIN; BRAIN MAPPING; CARRIER PROTEINS; DOPAMINE; DOPAMINE PLASMA MEMBRANE TRANSPORT PROTEINS; EPISTASIS, GENETIC; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; GLUTAMIC ACID; HEALTHY VOLUNTEERS; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; MAGNETIC RESONANCE IMAGING; MALE; POLYMORPHISM, SINGLE NUCLEOTIDE; PSYCHOTIC DISORDERS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SCHIZOPHRENIA; SYNAPTIC TRANSMISSION; VERBAL LEARNING;

EID: 84882682482     PISSN: 10659471     EISSN: 10970193     Source Type: Journal    
DOI: 10.1002/hbm.22061     Document Type: Article

References (126)

1. Aalto S, Ihalainen J, Hirvonen J, Kajander J, Scheinin H, Tanila H, Nagren K, Vilkman H, Gustafsson LL, Syvalahti E, Hietala J (2005): Cortical glutamate-dopamine interaction and ketamine-induced psychotic symptoms in man. Psychopharmacology (Berl) 182:375-383.
2. Abi-Dargham A, van de Giessen E, Slifstein M, Kegeles LS, Laruelle M (2009): Baseline and amphetamine-stimulated dopamine activity are related in drug-naive schizophrenic subjects. Biol Psychiatry 65:1091-1093.
3. Allen HA, Liddle PF, Frith CD (1993): Negative features, retrieval processes and verbal fluency in schizophrenia. Br J Psychiatry 163:769-775.
4. Alm PA (2004): Stuttering and the basal ganglia circuits: A critical review of possible relations. J Commun Disord 37:325-369.
5. Ammons RB, Ammons CH (1962): The Quick test. Missoula, MT: Psychological Test Specialists.
6. Artiges E, Martinot JL, Verdys M, Attar-Levy D, Mazoyer B, Tzourio N, Giraud MJ, Paillere-Martinot ML (2000): Altered hemispheric functional dominance during word generation in negative schizophrenia. Schizophr Bull 26:709-721.
7. Baldo JV, Schwartz S, Wilkins D, Dronkers NF (2006): Role of frontal versus temporal cortex in verbal fluency as revealed by voxel-based lesion symptom mapping. J Int Neuropsychol Soc 12:896-900.
8. Barch DM, Csernansky JG (2007): Abnormal parietal cortex activation during working memory in schizophrenia: Verbal phonological coding disturbances versus domain-general executive dysfunction. Am J Psychiatry 164:1090-1098.
9. Bertolino A, Blasi G, Latorre V, Rubino V, Rampino A, Sinibaldi L, Caforio G, Petruzzella V, Pizzuti A, Scarabino T, Nardini M, Weinberger DR, Dallapiccola B (2006): Additive effects of genetic variation in dopamine regulating genes on working memory cortical activity in human brain. J Neurosci 26:3918-3922.
10. Bertolino A, Di Giorgio A, Blasi G, Sambataro F, Caforio G, Sinibaldi L, Latorre V, Rampino A, Taurisano P, Fazio L, Romano R, Douzgou S, Popolizio T, Kolachana B, Nardini M, Weinberger DR, Dallapiccola B (2008): Epistasis between dopamine regulating genes identifies a nonlinear response of the human hippocampus during memory tasks. Biol Psychiatry 64:226-234.
11. Bilder RM, Volavka J, Lachman HM, Grace AA (2004): The catechol-O-methyltransferase polymorphism: relations to the tonic-phasic dopamine hypothesis and neuropsychiatric phenotypes. Neuropsychopharmacology 29:1943-1961.
12. Boks MP, Rietkerk T, van de Beek MH, Sommer IE, de Koning TJ, Kahn RS (2007): Reviewing the role of the genes G72 and DAAO in glutamate neurotransmission in schizophrenia. Eur Neuropsychopharmacol 17:567-572.
13. Caldu X, Vendrell P, Bartres-Faz D, Clemente I, Bargallo N, Jurado MA, Serra-Grabulosa JM, Junque C (2007): Impact of the COMT Val108/158 Met and DAT genotypes on prefrontal function in healthy subjects. Neuroimage 37:1437-1444.
14. Carlsson M, Carlsson A (1990): Interactions between glutamatergic and monoaminergic systems within the basal ganglia-Implications for schizophrenia and Parkinson's disease. Trends Neurosci 13:272-276.
15. Castner SA, Williams GV (2007): Tuning the engine of cognition: a focus on NMDA/D1 receptor interactions in prefrontal cortex. Brain Cogn 63:94-122.
16. Celsis P, Boulanouar K, Doyon B, Ranjeva JP, Berry I, Nespoulous JL, Chollet F (1999): Differential fMRI responses in the left posterior superior temporal gyrus and left supramarginal gyrus to habituation and change detection in syllables and tones. Neuroimage 9:135-144.
17. Chesselet MF (1990): Presynaptic regulation of dopamine release. Implications for the functional organization of the basal ganglia. Ann NY Acad Sci 604:17-22.
18. Chumakov I, Blumenfeld M, Guerassimenko O, Cavarec L, Palicio M, Abderrahim H, Bougueleret L, Barry C, Tanaka H, La Rosa P, et al. (2002): Genetic and physiological data implicating the new human gene G72 and the gene for D-amino acid oxidase in schizophrenia. Proc Natl Acad Sci USA 99:13675-13680.
19. Clower DM, West RA, Lynch JC, Strick PL (2001): The inferior parietal lobule is the target of output from the superior colliculus, hippocampus, and cerebellum. J Neurosci 21:6283-6291.
20. Costafreda SG, Fu CH, Picchioni M, Kane F, McDonald C, Prata DP, Kalidindi S, Walshe M, Curtis V, Bramon E, et al. (2009): Increased inferior frontal activation during word generation: A marker of genetic risk for schizophrenia but not bipolar disorder? Hum Brain Mapp 30:3287-3298.
21. Costafreda SG, Fu CH, Picchioni M, Toulopoulou T, McDonald C, Kravariti E, Walshe M, Prata D, Murray RM, McGuire PK (2011): Pattern of neural responses to verbal fluency shows diagnostic specificity for schizophrenia and bipolar disorder. BMC Psychiatry 11:18.
22. Curtis VA, Bullmore ET, Brammer MJ, Wright IC, Williams SC, Morris RG, Sharma TS, Murray RM, McGuire PK (1998): Attenuated frontal activation during a verbal fluency task in patients with schizophrenia. Am J Psychiatry 155:1056-1063.
23. Detera-Wadleigh SD, McMahon FJ (2006): G72/G30 in schizophrenia and bipolar disorder: Review and meta-analysis. Biol Psychiatry 60:106-114.
24. Dreher JC, Kohn P, Kolachana B, Weinberger DR, Berman KF (2009): Variation in dopamine genes influences responsivity of the human reward system. Proc Natl Acad Sci USA 106:617-622.
25. Duzel E, Cabeza R, Picton TW, Yonelinas AP, Scheich H, Heinze HJ, Tulving E (1999): Task-related and item-related brain processes of memory retrieval. Proc Natl Acad Sci USA 96:1794-1799.
26. Forbes EE, Brown SM, Kimak M, Ferrell RE, Manuck SB, Hariri AR (2009): Genetic variation in components of dopamine neurotransmission impacts ventral striatal reactivity associated with impulsivity. Mol Psychiatry 14:60-70.
27. Freeman B, Smith N, Curtis C, Huckett L, Mill J, Craig IW (2003): DNA from buccal swabs recruited by mail: Evaluation of storage effects on long-term stability and suitability for multiplex polymerase chain reaction genotyping. Behav Genet 33:67-72.
28. Friston KJ (2003): Introduction: Experimental design and statistical parametric mapping. In: Frackowiak RS, Friston KJ, Frith C, Dolan R, Price CJ, Zeki S, Ashburner J, Penny WD, editors. Human Brain Function. Academic Press: San Diego, California, USA, pp 599-634.
29. Frith CD, Friston KJ, Herold S, Silbersweig D, Fletcher P, Cahill C, Dolan RJ, Frackowiak RS, Liddle PF (1995): Regional brain activity in chronic schizophrenic patients during the performance of a verbal fluency task. Br J Psychiatry 167:343-349.
30. Fu CH, Morgan K, Suckling J, Williams SC, Andrew C, Vythelingum GN, McGuire PK (2002): A functional magnetic resonance imaging study of overt letter verbal fluency using a clustered acquisition sequence: Greater anterior cingulate activation with increased task demand. Neuroimage 17:871-879.
31. Fu CH, Suckling J, Williams SC, Andrew CM, Vythelingum GN, McGuire PK (2005): Effects of psychotic state and task demand on prefrontal function in schizophrenia: An fMRI study of overt verbal fluency. Am J Psychiatry 162:485-494.
32. Fuke S, Suo S, Takahashi N, Koike H, Sasagawa N, Ishiura S (2001): The VNTR polymorphism of the human dopamine transporter (DAT1) gene affects gene expression. Pharmacogenomics J 1:152-156.
33. Gamma F, Faraone SV, Glatt SJ, Yeh YC, Tsuang MT (2005): Meta-analysis shows schizophrenia is not associated with the 40-base-pair repeat polymorphism of the dopamine transporter gene. Schizophr Res 73:55-58.
34. Goldberg TE, Straub RE, Callicott JH, Hariri A, Mattay VS, Bigelow L, Coppola R, Egan MF, Weinberger DR (2006): The G72/G30 gene complex and cognitive abnormalities in schizophrenia. Neuropsychopharmacology 31:2022-2032.
35. Goldman-Rakic PS, Muly ECIII, Williams GV (2000): D(1) receptors in prefrontal cells and circuits. Brain Res Brain Res Rev 31(2-3):295-301.
36. Grace AA (1991): Phasic versus tonic dopamine release and the modulation of dopamine system responsivity: A hypothesis for the etiology of schizophrenia. Neuroscience 41:1-24.
37. Hall J, Whalley HC, Moorhead TW, Baig BJ, McIntosh AM, Job DE, Owens DG, Lawrie SM, Johnstone EC (2008): Genetic variation in the DAOA (G72) gene modulates hippocampal function in subjects at high risk of schizophrenia. Biol Psychiatry 64:428-433.
38. Haznedar MM, Buchsbaum MS, Hazlett EA, Shihabuddin L, New A, Siever LJ (2004): Cingulate gyrus volume and metabolism in the schizophrenia spectrum. Schizophr Res 71(2-3):249-262.
39. Heim S, Eickhoff SB, Amunts K (2008): Specialisation in Broca's region for semantic, phonological, and syntactic fluency? Neuroimage 40:1362-1368.
40. Heinz A, Goldman D, Jones DW, Palmour R, Hommer D, Gorey JG, Lee KS, Linnoila M, Weinberger DR (2000): Genotype influences in vivo dopamine transporter availability in human striatum. Neuropsychopharmacology 22:133-139.
41. Heresco-Levy U (2005): Glutamatergic neurotransmission modulators as emerging new drugs for schizophrenia. Expert Opin Emerg Drugs 10:827-844.
42. Holcomb HH, Lahti AC, Medoff DR, Weiler M, Dannals RF, Tamminga CA (2000): Brain activation patterns in schizophrenic and comparison volunteers during a matched-performance auditory recognition task. Am J Psychiatry 157:1634-1645.
43. Howanitz E, Cicalese C, Harvey PD (2000): Verbal fluency and psychiatric symptoms in geriatric schizophrenia. Schizophr Res 42:167-169.
44. Hulshoff Pol HE, Schnack HG, Mandl RC, van Haren NE, Koning H, Collins DL, Evans AC, Kahn RS (2001): Focal gray matter density changes in schizophrenia. Arch Gen Psychiatry 58:1118-1125.
45. Hutchinson M, Schiffer W, Joseffer S, Liu A, Schlosser R, Dikshit S, Goldberg E, Brodie JD (1999): Task-specific deactivation patterns in functional magnetic resonance imaging. Magn Reson Imaging 17:1427-1436.
46. Janowsky DS, Risch C (1979): Amphetamine psychosis and psychotic symptoms. Psychopharmacology (Berl) 65:73-77.
47. Jansen A, Krach S, Krug A, Markov V, Eggermann T, Zerres K, Stocker T, Shah NJ, Nothen MM, Treutlein J, Rietschel M, Kircher T (2009): A putative high risk diplotype of the G72 gene is in healthy individuals associated with better performance in working memory functions and altered brain activity in the medial temporal lobe. Neuroimage 45:1002-1008.
48. Jardri R, Pouchet A, Pins D, Thomas P (2011): Cortical activations during auditory verbal hallucinations in schizophrenia: A coordinate-based meta-analysis. Am J Psychiatry 168:73-81.
49. Jung WH, Kim JS, Jang JH, Choi JS, Jung MH, Park JY, Han JY, Choi CH, Kang DH, Chung CK, Kwon JS (2011): Cortical thickness reduction in individuals at ultra-high-risk for psychosis. Schizophr Bull 37(4):839-849.
50. Kiebel SJ, Glaser DE, Friston KJ (2003): A heuristic for the degrees of freedom of statistics based on multiple variance parameters. Neuroimage 20:591-600.
51. Kiehl KA, Liddle PF (2001): An event-related functional magnetic resonance imaging study of an auditory oddball task in schizophrenia. Schizophr Res 48(2-3):159-171.
52. Kircher TT, Liddle PF, Brammer MJ, Williams SC, Murray RM, McGuire PK (2001): Neural correlates of formal thought disorder in schizophrenia: Preliminary findings from a functional magnetic resonance imaging study. Arch Gen Psychiatry 58:769-774.
53. Korostishevsky M, Kaganovich M, Cholostoy A, Ashkenazi M, Ratner Y, Dahary D, Bernstein J, Bening-Abu-Shach U, Ben-Asher E, Lancet D, Ritsner M, Navon R (2004): Is the G72/G30 locus associated with schizophrenia? Single nucleotide polymorphisms, haplotypes, and gene expression analysis. Biol Psychiatry 56:169-176.
54. Krug A, Markov V, Krach S, Jansen A, Zerres K, Eggermann T, Stocker T, Shah NJ, Nothen MM, Georgi A, Strohmaier J, Rietschel M, Kircher T (2010): Genetic variation in G72 correlates with brain activation in the right middle temporal gyrus in a verbal fluency task in healthy individuals. Hum Brain Mapp 32:118-126.
55. Krystal JH, Perry EBJr, Gueorguieva R, Belger A, Madonick SH, Abi-Dargham A, Cooper TB, Macdougall L, Abi-Saab W, D'Souza DC (2005): Comparative and interactive human psychopharmacologic effects of ketamine and amphetamine: implications for glutamatergic and dopaminergic model psychoses and cognitive function. Arch Gen Psychiatry 62:985-994.
56. Kvajo M, Dhilla A, Swor DE, Karayiorgou M, Gogos JA (2008): Evidence implicating the candidate schizophrenia/bipolar disorder susceptibility gene G72 in mitochondrial function. Mol Psychiatry 13:685-696.
57. Law AJ, Deakin JF (2001): Asymmetrical reductions of hippocampal NMDAR1 glutamate receptor mRNA in the psychoses. Neuroreport 12:2971-2974.
58. Lewis DA, Melchitzky DS, Sesack SR, Whitehead RE, Auh S, Sampson A (2001): Dopamine transporter immunoreactivity in monkey cerebral cortex: Regional, laminar, and ultrastructural localization. J Comp Neurol 432:119-136.
59. Lindvall O, Bjorklund A (1978): Anatomy of the dopaminergic neuron systems in the rat brain. Adv Biochem Psychopharmacol 19:1-23.
60. Lisman JE, Coyle JT, Green RW, Javitt DC, Benes FM, Heckers S, Grace AA (2008): Circuit-based framework for understanding neurotransmitter and risk gene interactions in schizophrenia. Trends Neurosci 31:234-242.
61. Lodge DJ, Grace AA (2006): The hippocampus modulates dopamine neuron responsivity by regulating the intensity of phasic neuron activation. Neuropsychopharmacology 31:1356-1361.
62. Lodge DJ, Grace AA (2008): Hippocampal dysfunction and disruption of dopamine system regulation in an animal model of schizophrenia. Neurotox Res 14(2-3):97-104.
63. Lodge DJ, Grace AA (2009): Gestational methylazoxymethanol acetate administration: A developmental disruption model of schizophrenia. Behav Brain Res 204:306-312.
64. Lorang D, Amara SG, Simerly RB (1994): Cell-type-specific expression of catecholamine transporters in the rat brain. J Neurosci 14:4903-4914.
65. Lorrain DS, Baccei CS, Bristow LJ, Anderson JJ, Varney MA (2003): Effects of ketamine and N-methyl-D-aspartate on glutamate and dopamine release in the rat prefrontal cortex: Modulation by a group II selective metabotropic glutamate receptor agonist LY379268. Neuroscience 117:697-706.
66. Lurito JT, Kareken DA, Lowe MJ, Chen SH, Mathews VP (2000): Comparison of rhyming and word generation with FMRI. Hum Brain Mapp 10:99-106.
67. Maddock RJ, Garrett AS, Buonocore MH (2001): Remembering familiar people: The posterior cingulate cortex and autobiographical memory retrieval. Neuroscience 104:667-676.
68. Martinez D, Gelernter J, Abi-Dargham A, van Dyck CH, Kegeles L, Innis RB, Laruelle M (2001): The variable number of tandem repeats polymorphism of the dopamine transporter gene is not associated with significant change in dopamine transporter phenotype in humans. Neuropsychopharmacology 24:553-560.
69. Masson J, Riad M, Chaudhry F, Darmon M, Aidouni Z, Conrath M, Giros B, Hamon M, Storm-Mathisen J, Descarries L, El Mestikawy S (1999): Unexpected localization of the Na+/Cl-dependent-like orphan transporter, Rxt1, on synaptic vesicles in the rat central nervous system. Eur J Neurosci 11:1349-1361.
70. McGowan S, Lawrence AD, Sales T, Quested D, Grasby P (2004): Presynaptic dopaminergic dysfunction in schizophrenia: A positron emission tomographic [18F]fluorodopa study. Arch Gen Psychiatry 61:134-142.
71. Mechelli A, Prata DP, Fu CH, Picchioni M, Kane F, Kalidindi S, McDonald C, Demjaha A, Kravariti E, Toulopoulou T, Murray R, Collier DA, McGuire PK (2008): The effects of neuregulin1 on brain function in controls and patients with schizophrenia and bipolar disorder. Neuroimage 42:817-826.
72. Mill J, Asherson P, Browes C, D'Souza U, Craig I (2002): Expression of the dopamine transporter gene is regulated by the 3' UTR VNTR: Evidence from brain and lymphocytes using quantitative RT-PCR. Am J Med Genet 114:975-979.
73. Newman J, Grace AA (1999): Binding across time: The selective gating of frontal and hippocampal systems modulating working memory and attentional states. Conscious Cogn 8:196-212.
74. Nixon DC, Prust MJ, Sambataro F, Tan HY, Mattay VS, Weinberger DR, Callicott JH (2011): Interactive effects of DAOA (G72) and catechol-O-methyltransferase on neurophysiology in prefrontal cortex. Biol Psychiatry 69:1006--1008.
75. Niznikiewicz M, Donnino R, McCarley RW, Nestor PG, Iosifescu DV, O'Donnell B, Levitt J, Shenton ME (2000): Abnormal angular gyrus asymmetry in schizophrenia. Am J Psychiatry 157:428-437.
76. Northoff G, Richter A, Bermpohl F, Grimm S, Martin E, Marcar VL, Wahl C, Hell D, Boeker H (2005): NMDA hypofunction in the posterior cingulate as a model for schizophrenia: An exploratory ketamine administration study in fMRI. Schizophr Res 72(2-3):235-248.
77. Olney JW, Farber NB (1995): Glutamate receptor dysfunction and schizophrenia. Arch Gen Psychiatry 52:998-1007.
78. Olney JW, Labruyere J, Price MT (1989): Pathological changes induced in cerebrocortical neurons by phencyclidine and related drugs. Science 244:1360-1362.
79. Olney JW, Newcomer JW, Farber NB (1999): NMDA receptor hypofunction model of schizophrenia. J Psychiatr Res 33:523-533.
80. Opgen-Rhein C, Lencz T, Burdick KE, Neuhaus AH, DeRosse P, Goldberg TE, Malhotra AK (2008): Genetic variation in the DAOA gene complex: Impact on susceptibility for schizophrenia and on cognitive performance. Schizophr Res 103(1-3):169-177.
81. Owen M (2010): Imaging genetics in psychiatry: Disease path or garden path? Schizophrenia Res 117:123.
82. Papagni SA, Mechelli A, Prata DP, Kambeitz J, Fu CH, Picchioni M, Walshe M, Toulopoulou T, Bramon E, Murray RM, Collier DA, Bellomo A, McGuire P (2011): Differential effects of DAAO on regional activation and functional connectivity in schizophrenia, bipolar disorder and controls. Neuroimage 56:2283-2291.
83. Patil ST, Zhang L, Martenyi F, Lowe SL, Jackson KA, Andreev BV, Avedisova AS, Bardenstein LM, Gurovich IY, Morozova MA, et al. (2007): Activation of mGlu2/3 receptors as a new approach to treat schizophrenia: A randomized Phase 2 clinical trial. Nat Med 13:1102-1107.
84. Pierce CA, Block RA, Aguinis H (2004): Cautionary note on reporting Eta-squared values from multifactor ANOVA designs. Educational Psychol Measurement 64:916-924.
85. Pihlajamaki M, Tanila H, Hanninen T, Kononen M, Laakso M, Partanen K, Soininen H, Aronen HJ (2000): Verbal fluency activates the left medial temporal lobe: A functional magnetic resonance imaging study. Ann Neurol 47:470-476.
86. Pilowsky LS, Bressan RA, Stone JM, Erlandsson K, Mulligan RS, Krystal JH, Ell PJ (2006): First in vivo evidence of an NMDA receptor deficit in medication-free schizophrenic patients. Mol Psychiatry 11:118-119.
87. Prata DP, Mechelli A, Fu CH, Picchioni M, Kane F, Kalidindi S, McDonald C, Howes O, Kravariti E, Demjaha A, et al. (2009a) Opposite effects of catechol-O-methyltransferase Val158Met on cortical function in healthy subjects and patients with schizophrenia. Biol Psychiatry 65:473-480.
88. Prata DP, Mechelli A, Fu CH, Picchioni M, Kane F, Kalidindi S, McDonald C, Kravariti E, Toulopoulou T, Miorelli A, et al. (2008): The DISC1 Ser704Cys polymorphism is associated with prefrontal function in healthy individuals. Mol Psychiatry 13:909.
89. Prata DP, Mechelli A, Fu CH, Picchioni M, Toulopoulou T, Bramon E, Walshe M, Murray RM, Collier DA, McGuire P (2009b) Epistasis between the DAT 3' UTR VNTR and the COMT Val158Met SNP on cortical function in healthy subjects and patients with schizophrenia. Proc Natl Acad Sci USA 106:13600-13605.
90. Prata DP, Mechelli A, Picchioni MM, Fu CH, Toulopoulou T, Bramon E, Walshe M, Murray RM, Collier DA, McGuire P (2009c) Altered effect of dopamine transporter 3'UTR VNTR genotype on prefrontal and striatal function in schizophrenia. Arch Gen Psychiatry 66:1162-1172.
91. Prata DP, Papagni SA, Mechelli A, Fu CH, Kambeitz J, Picchioni M, Kane F, Kalidindi S, McDonald C, Kravariti E, et al. (2012): Effect of D-amino acid oxidase activator (DAOA; G72) on brain function during verbal fluency. Hum Brain Mapp 33:143--153.
92. Rabiner EA. 2007. Imaging of striatal dopamine release elicited with NMDA antagonists: Is there anything there to be seen? J Psychopharmacol 21:253-258.
93. Rios Valentim SJJr, Gontijo AV, Peres MD, Rodrigues LC, Nakamura-Palacios EM (2009): D1 dopamine and NMDA receptors interactions in the medial prefrontal cortex: Modulation of spatial working memory in rats. Behav Brain Res 204:124-128.
94. Rosen HJ, Ojemann JG, Ollinger JM, Petersen SE (2000): Comparison of brain activation during word retrieval done silently and aloud using fMRI. Brain Cogn 42:201-217.
95. Sacchi S, Bernasconi M, Martineau M, Mothet JP, Ruzzene M, Pilone MS, Pollegioni L, Molla G (2008): pLG72 modulates intracellular D-serine levels through its interaction with D-amino acid oxidase: Effect on schizophrenia susceptibility. J Biol Chem 283:22244-22256.
96. Schlosser R, Hutchinson M, Joseffer S, Rusinek H, Saarimaki A, Stevenson J, Dewey SL, Brodie JD (1998): Functional magnetic resonance imaging of human brain activity in a verbal fluency task. J Neurol Neurosurg Psychiatry 64:492-498.
97. Seeman P, Lee T (1975): Antipsychotic drugs: Direct correlation between clinical potency and presynaptic action on dopamine neurons. Science 188:1217-1219.
98. Shinkai T, De Luca V, Hwang R, Muller DJ, Lanktree M, Zai G, Shaikh S, Wong G, Sicard T, Potapova N, et al. (2007): Association analyses of the DAOA/G30 and D-amino-acid oxidase genes in schizophrenia: Further evidence for a role in schizophrenia. Neuromolecular Med 9:169-177.
99. Spence SA, Liddle PF, Stefan MD, Hellewell JS, Sharma T, Friston KJ, Hirsch SR, Frith CD, Murray RM, Deakin JF, et al. (2000): Functional anatomy of verbal fluency in people with schizophrenia and those at genetic risk. Focal dysfunction and distributed disconnectivity reappraised. Br J Psychiatry 176:52-60.
100. Stone JM, Pilowsky LS (2006): Psychopathological consequences of ketamine. Br J Psychiatry 189:565-566.
101. Stone JM, Morrison PD, Pilowsky LS (2007): Glutamate and dopamine dysregulation in schizophrenia-A synthesis and selective review. J Psychopharmacol 21:440-452.
102. Stone JM, Howes OD, Egerton A, Kambeitz J, Allen P, Lythgoe DJ, O'Gorman RL, McLean MA, Barker GJ, McGuire P (2010): Altered relationship between hippocampal glutamate levels and striatal dopamine function in subjects at ultra high risk of psychosis. Biol Psychiatry 68:599-602.
103. Sutherland RJ, Whishaw IQ, Kolb B (1988): Contributions of cingulate cortex to two forms of spatial learning and memory. J Neurosci 8:1863-1872.
104. Tanskanen P, Ridler K, Murray GK, Haapea M, Veijola JM, Jaaskelainen E, Miettunen J, Jones PB, Bullmore ET, Isohanni MK (2010): Morphometric brain abnormalities in schizophrenia in a population-based sample: Relationship to duration of illness. Schizophr Bull 36:766-777.
105. Tendolkar I, Weis S, Guddat O, Fernandez G, Brockhaus-Dumke A, Specht K, Klosterkotter J, Reul J, Ruhrmann S (2004): Evidence for a dysfunctional retrosplenial cortex in patients with schizophrenia: A functional magnetic resonance imaging study with a semantic-perceptual contrast. Neurosci Lett 369:4-8.
106. Tisch S, Silberstein P, Limousin-Dowsey P, Jahanshahi M (2004): The basal ganglia: Anatomy, physiology, and pharmacology. Psychiatr Clin North Am 27:757-799.
107. Tost H, Alam T, Meyer-Lindenberg A (2010): Dopamine and psychosis: Theory, pathomechanisms and intermediate phenotypes. Neurosci Biobehav Rev 34:689-700.
108. van Dyck CH, Malison RT, Jacobsen LK, Seibyl JP, Staley JK, Laruelle M, Baldwin RM, Innis RB, Gelernter J (2005): Increased dopamine transporter availability associated with the 9-repeat allele of the SLC6A3 gene. J Nucl Med 46:745-751.
109. Vandenbergh DJ, Persico AM, Hawkins AL, Griffin CA, Li X, Jabs EW, Uhl GR (1992): Human dopamine transporter gene (DAT1) maps to chromosome 5p15.3 and displays a VNTR. Genomics 14:1104-1106.
110. Vann SD, Aggleton JP (2002): Extensive cytotoxic lesions of the rat retrosplenial cortex reveal consistent deficits on tasks that tax allocentric spatial memory. Behav Neurosci 116:85-94.
111. VanNess SH, Owens MJ, Kilts CD (2005): The variable number of tandem repeats element in DAT1 regulates in vitro dopamine transporter density. BMC Genet 6:55.
112. Vogt BA, Finch DM, Olson CR. 1992. Functional heterogeneity in cingulate cortex: The anterior executive and posterior evaluative regions. Cereb Cortex 2:435-443.
113. Wang GJ, Volkow ND, Fowler JS, Ding YS, Logan J, Gatley SJ, MacGregor RR, Wolf AP (1995): Comparison of two pet radioligands for imaging extrastriatal dopamine transporters in human brain. Life Sci 57:PL187-PL191.
114. Wang J, Brown R, Dobkins KR, McDowell JE, Clementz BA (2009): Diminished parietal cortex activity associated with poor motion direction discrimination performance in schizophrenia. Cereb Cortex 20:1749-1755.
115. Wechsler D (1997): Wechsler Adult Intelligence Scale-Third Edition Manual. San Antonio, TX: Psychological Corporation.
116. Wechsler D (1981): Manual for the Wechsler Intelligence Scale-Revised. San Antonio, TX: The Psychological Corporation.
117. Wechsler D (1999): Wechsler Abbreviated Scale of Intelligence. San Antonia, TX: Psychological Corporation.
118. Weinberger DR (2010): On the matter of neuroimaging in the context of schizophrenia genetics. Schizophrenia Res 117:109-110.
119. Wheeler DG, Harper CG (2007): Localised reductions in gyrification in the posterior cingulate: Schizophrenia and controls. Prog Neuropsychopharmacol Biol Psychiatry 31:319-327.
120. Winterer G, Weinberger DR (2004): Genes, dopamine and cortical signal-to-noise ratio in schizophrenia. Trends Neurosci 27:683-690.
121. Wylie KP, Tregellas JR (2010): The role of the insula in schizophrenia. Schizophr Res 123(2-3):93-104.
122. Xiao Z, Zhang JX, Wang X, Wu R, Hu X, Weng X, Tan LH (2005): Differential activity in left inferior frontal gyrus for pseudowords and real words: An event-related fMRI study on auditory lexical decision. Hum Brain Mapp 25:212-221.
123. Yacubian J, Sommer T, Schroeder K, Glascher J, Kalisch R, Leuenberger B, Braus DF, Buchel C (2007): Gene-gene interaction associated with neural reward sensitivity. Proc Natl Acad Sci USA 104:8125-8130.
124. Yang CR, Chen L (2005): Targeting prefrontal cortical dopamine D1 and N-methyl-D-aspartate receptor interactions in schizophrenia treatment. Neuroscientist 11:452-470.
125. Yetkin FZ, Hammeke TA, Swanson SJ, Morris GL, Mueller WM, McAuliffe TL, Haughton VM (1995): A comparison of functional MR activation patterns during silent and audible language tasks. AJNR Am J Neuroradiol 16:1087-1092.
126. Yurgelun-Todd DA, Waternaux CM, Cohen BM, Gruber SA, English CD, Renshaw PF (1996): Functional magnetic resonance imaging of schizophrenic patients and comparison subjects during word production. Am J Psychiatry 153:200-205.